Last week BIOEMTECH team completed the installation of a γ-eye™ at the MIZZOU Molecular Imaging and Theranostics Center (MITC) at the University of Missouri-Columbia, preparing it to support upcoming SPECT imaging studies. Among the upcoming studies, ²¹²Pb stands out as a particularly promising alpha-emitting isotope, attracting growing interest for its therapeutic potential in targeted radioligand therapy.
It was a pleasure setting up the system at Dr. Bauer’s lab, and we are excited to see how it will contribute to the group’s research efforts.
Many thanks to David Bauer and Carolyn Anderson, Director of MITC, for the warm welcome and fruitful collaboration!